Literature DB >> 29720377

Analgesic effects of electroacupuncture at ST25 and CV12 in a rat model of postinflammatory irritable bowel syndrome visceral pain.

Xianwei Zhu1, Zhibin Liu1,2, Yifei Qin1, Wenmin Niu1,2, Qiang Wang1, Lu Li2, Jing Zhou3.   

Abstract

BACKGROUND: Treatment with electroacupuncture (EA) at ST25 and CV12 has a significant analgesic effect on postinflammatory irritable bowel syndrome (PI-IBS) visceral pain. Enterochromaffin (EC) cells and serotonin (5-hydroxytryptamine (5-HT)) are important in the development of visceral hyperalgesia.
OBJECTIVE: To investigate the analgesic effect and underlying mechanisms of EA at ST25 and CV12 on the treatment of trinitrobenzene sulfonic acid (TNBS)-induced PI-IBS visceral hyperalgesia in rats.
METHODS: After EA at ST25 and CV12, changes in abdominal withdrawal reflex (AWR), electromyography (EMG) recordings, colonic EC cell numbers, and expression of tryptophan hydroxylase (TPH), 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) of TNBS-induced PI-IBS visceral hyperalgesia in rats were examined.
RESULTS: The results of AWR tests and EMG recordings indicated a significant analgesic effect of EA stimulation at ST25 and CV12on PI-IBS visceral hyperalgesia (p<0.05). In addition, the increased EC cell numbers and colonic expression of TPH and 5-HT in rats with TNBS-induced PI-IBS visceral hyperalgesia were significantly reduced by EA (p<0.05).
CONCLUSIONS: EA stimulation at ST25 and CV12 can attenuate visceral hyperalgesia. This analgesic effect may be mediated via reduction of both colonic EC cell number and 5-HT concentration. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Tianshu (ST25) and Zhongwan (CV12); enterochromaffin (EC) cell; postinflammatory irritable bowel syndrome; serotonin (5-hydroxytrypamine [5-HT]); visceral hyperalgesia

Mesh:

Substances:

Year:  2018        PMID: 29720377     DOI: 10.1136/acupmed-2016-011320

Source DB:  PubMed          Journal:  Acupunct Med        ISSN: 0964-5284            Impact factor:   2.267


  6 in total

1.  Spinal cord astrocyte P2X7Rs mediate the inhibitory effect of electroacupuncture on visceral hypersensitivity of rat with irritable bowel syndrome.

Authors:  Zhi-Jun Weng; Shi-Xiu Hu; Fang Zhang; Zhi-Ying Zhang; Yun Zhou; Min Zhao; Yan Huang; Yu-Hu Xin; Huan-Gan Wu; Hui-Rong Liu
Journal:  Purinergic Signal       Date:  2022-04-07       Impact factor: 3.765

2.  Therapeutic mechanism of steaming umbilical cord therapy with Chinese herbal medicine on a rat model of IBS-D via the PAR-2/TRVP1 pathway.

Authors:  Xiaohui Wang; Yang Lan; Zhongping Zeng; Laian Ge
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Electroacupuncture Relieves Visceral Hypersensitivity by Inactivating Protease-Activated Receptor 2 in a Rat Model of Postinfectious Irritable Bowel Syndrome.

Authors:  Wanli Xu; Mengqian Yuan; Xiaoliang Wu; Hao Geng; Lu Chen; Junling Zhou; Yafang Song; Lixia Pei; Jianhua Sun
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-18       Impact factor: 2.629

4.  Electro-Acupuncture Alleviates Cisplatin-Induced Anorexia in Rats by Modulating Ghrelin and Monoamine Neurotransmitters.

Authors:  Ji Yun Baek; Tuy An Trinh; Wonsang Huh; Ji Hoon Song; Hyun Young Kim; Juhee Lim; Jinhee Kim; Hyun Jin Choi; Tae-Hun Kim; Ki Sung Kang
Journal:  Biomolecules       Date:  2019-10-18

5.  Electroacupuncture Attenuates Post-Inflammatory IBS-Associated Visceral and Somatic Hypersensitivity and Correlates With the Regulatory Mechanism of Epac1-Piezo2 Axis.

Authors:  Jing Guo; Lu Chen; Yu-Hang Wang; Ya-Fang Song; Zhan-Hao Zhao; Ting-Ting Zhao; Zhi-Ying Lin; Dong-Mei Gu; Yun-Qi Liu; Yong-Jun Peng; Li-Xia Pei; Jian-Hua Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

6.  Electroacupuncture Alleviates Diabetic Peripheral Neuropathy by Regulating Glycolipid-Related GLO/AGEs/RAGE Axis.

Authors:  Xuan Wang; Qian Li; Xu Han; Meirong Gong; Zhi Yu; Bin Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-06       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.